Skip to search formSkip to main contentSkip to account menu

BMS 186295

Known as: BMS-186295 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

irbesartan

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2002
Review
2002
[Irbesartan--antihypertensive treatment in patients with heart failure and diabetes mellitus].
Irbesartan (SR 47436; BMS-186295) is a selective non-peptide antagonist of angiotensin II type 1 receptor (AT1). Irbesartan… 
1997
1997
Effect of high-performance liquid chromatography on plasma angiotensin II measurements in treated and untreated normotensive and hypertensive patients.
BACKGROUND Angiotensin II (Ang II) levels are normally very low in human plasma, approximately 5 pg/ml. They are usually measured… 
1997
1997
Angiotensin II subtype-1 receptor blockade during the development of left ventricular hypertrophy in dogs: effects on ventricular and myocyte function.
Inhibition of the angiotensin-converting enzyme (ACE) in developing left ventricular (LV) hypertrophy has been demonstrated to… 
1995
1995
727-4 Differential Effects of Chronic Angiotensin Converting Enzyme (ACE) Inhibition and Angiotensin II (AT-II) Receptor (AT1AT-II) Blockade on Myocyte Excitation and Contraction in Dilated…
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)